ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,805 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryAnièresIREMIS Therapeutics SA
IREMIS Therapeutics SA Logo
Verified· 2 sources

IREMIS Therapeutics SA

Summary

About the company

IREMIS Therapeutics SA develops therapeutic and theranostic solutions for neuropathic and other chronic pain conditions using a personalized medicine approach. The company is advancing its lead molecule IRX-001 (NDMC) in Phase II clinical development and applies pharmacogenetics, evidence‑based dosing guidance and patient monitoring to optimize treatment.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of therapeutic solutions for chronic pain
Therapeutic and theranostic solutions for the treatment of neuropathic pain and other chronic pain conditions, with personalised medicine, dose adjustment and pharmacogenetic application.
Clinical development of IRX-001 (NDMC)
Clinical development of the lead compound IRX-001 (NDMC) for neuropathic pain, including Phase I and Phase IIa studies, as well as efficacy and tolerability data.
Research on GABA-A receptor modulation
Research into differential allosteric modulation of the GABA-A receptor, focusing on α2-mediated pain inhibition and avoiding sedative effects.
Preclinical pain research
Preclinical models and data on central sensitisation and neuropathic pain, including dose-dependent antihyperalgesic effects and a safety profile.

Knowledge

No knowledge articles yet

Once IREMIS Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

IREMIS Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank IREMIS Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of IREMIS Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Route d'Hermance 320
1247 Anières

At a glance

Legal form
Corporation
UID
CHE-386.085.813
Founded
2024 · 2 years
Last commercial register change
September 19, 2024
Employees
1 to 10

Similar companies

S(
Sanofi-Aventis (Suisse) SA
Vernier
AP
ARmox Pharma Sàrl
Geneva
BS
Bluefilm Sàrl
Vésenaz
AT
AMAL THERAPEUTICS SA
Geneva